Retinal Physician

JAN-FEB 2017

Issue link: http://retinalphysician.epubxp.com/i/783300

Contents of this Issue

Navigation

Page 31 of 71

† Disease flare is defined by an increase in 1 or more inflammatory markers: AC cells, vitreous haze, and/or development of new chorioretinal and/or retinal vascular lesions. *Intermediate, posterior, and panuveitis. NON-INFECTIOUS (NI) UVEITIS * CAN BE HARD TO CONTROL. Visit www.HumiraPro.com/uveitis to learn more. For adult patients with non-infectious (NI) intermediate, posterior, and panuveitis 1 HUMIRA is proven to 1 : • Provide steroid-sparing efficacy • Prolong time to a combined measure of disease flare † and decrease of visual acuity

Articles in this issue

Links on this page

Archives of this issue

view archives of Retinal Physician - JAN-FEB 2017